The Hail Creek coal mine in Australia emits between three and eight times more methane than it reports, according to a new ...

One half of J&J’s treatment is Lazcluze, a pill that, like Astra’s Tagrisso, blocks a cancer-associated protein called EGFR.

Fintel reports that on March 27, 2025, JP Morgan initiated coverage of Mereo BioPharma Group plc - Depositary Receipt () ...

Research shows phospholipid complexation enhances CBD's solubility and absorption, paving the way for more effective ...

A study conducted by CED Romania and Accenture, with the support of the European Accessibility Resource Centre AccessibleEU, ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta progressing toward second interim analysis, expected mid-2025 Alvelestat granted Orphan Designation by the European Commission for treatmen ...

Cardiac electrophysiologist Dr. Jonathan Piccini says Medtronic's Define AFib study offers important lessons for other device ...

Analysis of Global Burden of Disease 2021 data showed the overall burden of primary liver cancer in the US has increased over the past 2 decades.

On Monday, Silence Therapeutics plc (NASDAQ:SLN) presented end-of-treatment data from its Phase 2 ALPACAR-360 study of zerlasiran in atherosclerotic cardiovascular disease (ASCVD) patients with ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, will present a ...